Association of PTPN22 C1858T polymorphism and type 1 diabetes: A meta-analysis

Immunological Investigations

Volumn 41, Issue 5, 2012, Pages 484-496

  Peng, Hui ^a   Zhou, Mo ^a   Xu, Wang Dong ^a   Xu, Ke ^a   Zhai, Yu ^a   Li, Rui ^a   Wang, Wei ^a   Zhang, Yu Jing ^a   Liu, Shan Shan ^a   Pan, Hai Feng ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Protein tyrosine phosphatase nonreceptor 22; Type 1 diabetes

Indexed keywords

ALLELE; ARTICLE; DISEASE ASSOCIATION; DNA POLYMORPHISM; ETHNIC DIFFERENCE; ETHNICITY; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS (TOPIC); POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22 C1858T GENE; PUBLISHING;

DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 84861921549     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.664226     Document Type: Article

References (45)

1. Arasteh, J.M., Sarvestani, E.K., Aflaki, E., Amirghofran, Z. (2010). Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules. Immunol. Invest. 39:27-38.
2. Baniasadi, V., Das, S.N. (2008). No evidence for association of PTPN22 R620W functional variant C1858T with type 1 diabetes in Asian Indians. J. Cell Mol. Med. 12:1061-1062. (Pubitemid 351718082)
3. Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J., Meloni, G.F., Lucarelli, P., Pellecchia, M., et al. (2004). A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36:337-338. (Pubitemid 38437254)
4. Chagastelles, P.C., Romitti, M., Trein, M.R., Bandinelli, E., Tschiedel, B., Nardi, N.B. (2010). Association between the 1858T allele of the protein tyrosine phosphatase nonreceptor type 22 and type 1 diabetes in a Brazilian population. Tissue Antigens 76:144-148.
5. Chelala, C., Duchatelet, S., Joffret, M.L., Bergholdt, R., Dubois-Laforgue, D., Ghandil, P., Pociot, F., Caillat-Zucman, S., Timsit, J., Julier, C. (2007). PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes 56:522-526.
6. Cinek, O., Hradsky, O., Ahmedov, G., Slavcev, A., Kolouskova, S., Kulich, M., Sumnik, Z. (2007). No independent role of the -1123 G > C and + 2740 A > G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabetes Res. Clin. Pract. 76:297-303. (Pubitemid 46400129)
7. Cohen, S., Dadi, H., Shaoul, E., Sharfe, N., Roifman, C.M. (1999). Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93:2013-2024. (Pubitemid 29128504)
8. DerSimonian, R., Laird, N. (1986). Meta-analysis in clinical trials. Control. Clin. Trials 7: 177-188. (Pubitemid 17189972)
9. Douroudis, K., Prans, E., Haller, K., Nemvalts, V., Rajasalu, T., Tillmann, V., Kisand, K., Uibo, R. (2008). Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population. Tissue Antigens 72:425-430.
10. Dultz, G., Matheis, N., Dittmar, M., Röhrig, B., Bender, K., Kahaly, G.J. (2009). The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 19:143-148.
11. Egger, M., Davey Smith, G., Schneider, M., Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 315:629-634. (Pubitemid 27387172)
12. Fedetz, M., Matesanz, F., Caro-Maldonado, A., Smirnov, I.I., Chvorostinka, V.N., Moiseenko, T.A., Alcina, A. (2006). The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population. Tissue Antigens 67:430-433.
13. Fichna, M., Zurawek, M., Januszkiewicz-Lewandowska, D., Fichna, P., Nowak, J. (2010). PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. Int. J. Immunogenet. 37:367-372.
14. Gomez, L.M., Anaya, J.M., Gonzalez, C.I., Pineda-Tamayo, R., Otero, W., Arango, A., Martín, J. (2005). PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun. 6:628-631. (Pubitemid 41637670)
15. Hermann, R., Lipponen, K., Kiviniemi, M., Kakko, T., Veijola, R., Simell, O., Knip, M., Ilonen, J. (2006). Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 49:1198-1208.
16. Higgins, J.P., Thompson, S.G. (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21:1539-1558. (Pubitemid 34746062)
17. Jamshidian, A., Nikseresht, A.R., Vessal, M., Kamali-Sarvestani, E. (2010). Association of CD1A +622 T/C, +737 G/C and CD1E +6129 A/G genes polymorphisms with multiple sclerosis. Immunol. Invest. 39:874-889.
18. Kahles, H., Ramos-Lopez, E., Lange, B., Zwermann, O., Reincke, M., Badenhoop, K. (2005). Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur. J. Endocrinol. 153:895-899. (Pubitemid 43020241)
19. Kawasaki, E., Awata, T., Ikegami, H., Kobayashi, T., Maruyama, T., Nakanishi, K., Shimada, A., Uga, M., Kurihara, S., Kawabata, Y., et al. (2006). Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am. J. Med. Genet. A 140:586-593. (Pubitemid 43376295)
20. Kordonouri, O., Hartmann, R., Badenhoop, K., Kahles, H., Ilonen, J. (2010). PTPN22 1858T allele is associated with younger age at onset of type 1 diabetes and is not related to subsequent thyroid autoimmunity. Hum. Immunol. 71:731-732.
21. korolija, M., Renar, I.P., Hadzija, M., Medvidović, E.P., Pavković, P., Jokić, M., Hadzija, M.P. (2009). Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 Diabetes in Croatians. Diabetes Res. Clin. Pract. 86:e54-57.
22. Lee, Y.H., Rho, Y.H., Choi, S.J., Ji, J.D., Song, G.G., Nath, S.K., Harley, J.B. (2007). The PTPN22 C1858T functional polymorphism and autoimmune diseases-A metaanalysis. Rheumatology (Oxford) 46:49-56. (Pubitemid 44932783)
23. Mantel, N., Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22:719-748.
24. Marrack, P., Kappler, J., Kotzin, B.L. (2001). Autoimmune disease: why and where it occurs. Nat. Med. 7:899-905. (Pubitemid 32756426)
25. Mosaad, Y.M., Elsharkawy, A.A., El-Deek, B.S. (2012). Association of CTLA-4 (+49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children. Immunol. Invest. 41:28-37.
26. Nielsen, C., Hansen, D., Husby, S., Lillevang, S.T. (2007). Sex-specific association of the human PTPN22 1858T-allele with type 1 diabetes. Int. Immunogenet 34:469-473. (Pubitemid 350126016)
27. Petitti DB. (1994). Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press.
28. Petrone, A., Suraci, C., Capizzi,M., Giaccari, A., Bosi, E., Tiberti, C., Cossu, E., Pozzilli, P., Falorni, A., Buzzetti, R., et al. (2008). The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care 31:534-538.
29. Pugliese, A. (2004). Genetics of type 1 diabetes. Endocrinol. Metab. Clin. North. Am. 33:1-16, vii.
30. Pugliese, A., Eisenbarth, G.S. (2004). Type 1 diabetes mellitus of man: genetic susceptibility and resistance. Adv. Exp .Med. Biol. 552:170-203. (Pubitemid 40103424)
31. Santiago, J.L., Martínez, A., de la Calle, H., Fernández-Arquero, M., Figueredo, M.A., de la Concha, E.G., Urcelay, E. (2007). Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population. BMC Med. Genet. 13:54.
32. She, J.X. (1996).Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunol. Today 17:323-329.
33. Smyth,D.,Cooper, J.D., Collins, J.E.,Heward, J.M., Franklyn, J.A.,Howson, J.M.,Vella,A., Nutland, S., Rance, H.E., Maier, L, et al. (2004). Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53: 3020-3023. (Pubitemid 39425931)
34. Smyth, D.J., Cooper, J.D., Howson, J.M., Walker, N.M., Plagnol, V., Stevens, H., Clayton, D.G., Todd, J.A. (2008). PTPN22 Trp 620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes. Diabetes 57:1730-1737.
35. Steck, A.K., Liu, S.Y., McFann, K., Barriga, K.J., Babu, S.R., Eisenbarth, G.S., Rewers, M.J., She, J.X. (2006). Association of the PTPN22/LYP gene with type 1 diabetes. Pediatr. Diabetes 7:274-278. (Pubitemid 44593928)
36. Stene, L.C., Rønningen, K.S., Bjørnvold, M., Undlien, D.E., Joner, G. (2010). An inverse association between history of childhood eczema and subsequent risk of type 1 diabetes that is not likely to be explained by HLA-DQ, PTPN22, or CTLA4 polymorphisms. Pediatr. Diabetes 11:386-393.
37. Tao, J.H., Zou, Y.F., Feng, X.L., Li, J., Wang, F., Pan, F.M., Ye, D.Q. (2011). Metaanalysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases. Mol. Biol. Rep. 38:4663-4672.
38. Todd, J.A., Walker, N.M., Cooper, J.D., Smyth, D.J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., Field, S.F., Payne, F., (2007). Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39:857-864. (Pubitemid 47018195)
39. Vang, T., Miletic, A.V., Bottini, N., Mustelin, T. (2007). Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 40:453-461. (Pubitemid 47343357)
40. Wandstrat, A., Wakeland, E. (2001). The genetics of complex autoimmune diseases: non- MHC susceptibility genes. Nat. Immunol. 2:802-809.
41. Wang, H., Yang, J., Jin, L., Feng, J., Lu, Y., Sun, Y., Li, T., Cao, R., Wu, J., Fan, H., et al. (2009). Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides. Immunol. Invest. 38:690-703.
42. Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678.
43. Zhebrun, D., Kudryashova, Y., Babenko, A., Maslyansky, A., Kunitskaya, N., Popcova, D., Klushina, A., Grineva, E., Kostareva, A., Shlyakhto, E. (2011). Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population. Aging (Albany, NY) 3:368-373.
44. Zheng, W., She, J.X. (2005). Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes 54:906-908. (Pubitemid 40322097)
45. Zhernakova, A., Eerligh, P., Wijmenga, C., Barrera, P., Roep, B.O., Koeleman, B.P. (2005). Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes Immun. 6:459-461. (Pubitemid 43090502)